Page last updated: 2024-11-12

sargachromanol g

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sargachromanol G: isolated from the brown algae Sargassum siliquastrum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11407674
CHEMBL ID462917
MeSH IDM0580225

Synonyms (5)

Synonym
sargachromanol g
CHEMBL462917
bdbm50483666
DTXSID801045700
856414-56-7
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID590287Antifungal activity against Aspergillus fumigatus HIC 6094 at 100 ug/ml after 2 weeks2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590286Antifungal activity against Candida albicans ATCC 10231 at 100 ug/ml after 2 weeks2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590291Antifungal activity against Trichophyton mentagrophytes IFO 40996 at 100 ug/ml after 2 weeks2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590285Antibacterial activity against Proteus vulgaris ATCC 3851 after 24 hrs by by broth dilution method2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590280Inhibition of porcine cerebral cortex Na+/K+ ATPase by spectrophotometry2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590290Antifungal activity against Trichophyton rubrum IFO 9185 at 100 ug/ml after 2 weeks2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590284Antibacterial activity against Micrococcus luteus IFC 12708 after 24 hrs by by broth dilution method2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590283Antibacterial activity against Staphylococcus aureus ATCC 6538p after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID401695Inhibition of butylcholine esterase at 100 ug/mL2005Journal of natural products, May, Volume: 68, Issue:5
Chromenes from the brown alga Sargassum siliquastrum.
AID590282Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590281Inhibition of Candida albicans ICL assessed as formation of glyoxylate phenylhydrazone by spectrophotometry2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590289Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID590288Antibacterial activity against Salmonella Typhimurium ATCC 14028 after 24 hrs by broth dilution method2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase.
AID401694Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/mL2005Journal of natural products, May, Volume: 68, Issue:5
Chromenes from the brown alga Sargassum siliquastrum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.28 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]